Arrow International Catheter Recall Follows Reports Of Vessel Erosion
This article was originally published in The Gray Sheet
Executive Summary
Arrow International is investigating its NeoPICC 1.9 Fr peripherally inserted central catheters to determine the root-cause of adverse events that prompted a roughly 20,000-unit nationwide recall